The Government of India, through the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer medicines. The aim is to make cancer treatment more affordable for patients.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Oncology Division plays a key role in strengthening cancer treatment by offering a diverse range of oncology and haematology therapies. This division provides advanced pharmaceutical solutions that support the management of various cancers and blood-related disorders. By partnering with healthcare professionals and applying scientific advancements, the Hetero Oncology Division stay committed to improving cancer care and providing access to life-enhancing treatments.
View by-
